@FiercePharma: ICYMI: This week's full issue of FiercePharmaMarketing. Subscribe here. | Follow @FiercePharma
@CarlyHFierce: U.K. health secretary: Novartis holding government to 'ransom' with Bexsero pricing. FierceVaccines article | Follow @CarlyHFierce
> India's Cipla has entered the vaccines space with a deal with the Serum Institute of India, whose low-cost pediatric vaccines it will market in Europe. More
> Amgen ($AMGN) has opened a $200 million continuous purification plant in Singapore. More
> Perrigo says it plans to sell $900 million in stock to fund its acquisition of Belgium's Omega Pharma. Report (sub. req.)
> Multinational pharmas are selling their drugs at higher prices in South Korea than in other countries, a report says. More
> AstraZeneca ($AZN) has priced a new debt issue of 750 million in euro-denominated notes. Report
Medical Device News
@FierceMedDev: From FierceDrugDelivery: Medical marijuana company licenses RapidMist device for buccal delivery. Story | Follow @FierceMedDev
@StacyALawrence: Second Sight IPO pops 122% in first day. That's 8th largest IPO pop this year in any sector. Updated story | Follow @StacyALawrence
@VarunSaxena2: Smith & Nephew closes U.S. facility, sells another in U.K. with 100+ to be laid off. More | Follow @VarunSaxena2
@EmilyWFierce: More on how the Cystic Fibrosis Foundation's deal with Royalty Pharma could affect R&D and patients. NYT story | Follow @EmilyWFierce
> Smith & Nephew closes a facility in the U.S., sells another in the UK, 100+ to be laid off. More
> New paradigms in diagnostics: graphene and a single drop of blood. Editor's Corner
> Molecular nuclear imaging startup to use $100M IPO to advance Phase III therapeutic. Article
Biotech News
@FierceBiotech: Success or failure, feds want trial results posted online. Article | Follow @FierceBiotech
@JohnCFierce: U.K. heavyweight Woodford gambles $25M on controversial brain cancer vaccine. Report | Follow @JohnCFierce
@DamianFierce: Important M&A code name update from @BloombergNews: $AGN was "Avocado" to $ACT and "Apollo" to $VRX. Article | Follow @DamianFierce
> U.K. heavyweight Woodford gambles $25M on controversial brain cancer vaccine. Article
> Success or failure, feds want trial results posted online. More
> Sanofi sticks to Viehbacher's R&D script as it rolls out a $38B pipeline vision. Story
Vaccines News
> PATH chooses Mymetics for work on transmission-blocking malaria vax. Item
> U.K. health secretary: Novartis holding government to 'ransom' with Bexsero pricing. More
> Pfizer's MenB reach--and lead on Novartis--limited without ACIP nod. Report
> NewLink Ebola vaccine trial to start in Canada. Article
> Celldex glioblastoma vaccine extends survival in Phase II. Story
Pharma Manufacturing News
> Ranbaxy can't stop the FDA from yanking drug approvals over plant problems. Item
> Amgen opens $200M continuous purification plant in Singapore. Story
> Doc coughs up $2M for using unapproved Avastin on his cancer patients. Report
> Interpol: Organized crime, aware of weak points, targets counterfeit drugs. Story
> U.K. generics maker to build $31M plant in Alabama. Article
And Finally... The British government has launched a review to speed the path to market for new drugs. Report